Featured Research

from universities, journals, and other organizations

New Compound May Permit Definitive Diagnosis And Treatment Monitoring Of Alzheimer's In Living Patients

Date:
June 27, 2000
Source:
University Of Pennsylvania Medical Center
Summary:
University of Pennsylvania School of Medicine researchers have created a stealth-like molecule, called BSB, that can effectively breach the obstinate blood-brain barrier in mouse models and bind specifically and sufficiently to the resident plaque formations so that they can be visualized by existing imaging techniques.

Penn scientists create first plaque-binding molecular probe in animal model that effectively passes the blood-brain barrier

Related Articles


Philadelphia, PA -- Planned clinical strategies to treat Alzheimer's disease (AD) will involve the use of drugs designed to decrease or eliminate the formation of waxy extracellular clumps, or amyloid plaques, that appear in the brains of AD patients and which are believed to contribute to the inevitable decline in neurological function. Unfortunately, the effectiveness of such drugs cannot be determined as no method currently exists that permits physicians to visually monitor changes in the plaque formations of the brains of living patients. Such monitoring would require the development of a probe, or dye-like compound, capable of not only crossing the stalwart blood-brain barrier but subsequently binding to the plaque formations so that visualization of the amyloid clumps could occur using PET or SPECT imaging.

An innovative solution to that problem may have been found in the work done by researchers at the University of Pennsylvania School of Medicine. There, Virginia M.-Y. Lee, MD, and her team have created a stealth-like molecule, called BSB, that can effectively breach the obstinate blood-brain barrier in mouse models and bind specifically and sufficiently to the resident plaque formations so that they can be visualized by existing imaging techniques. Their work -- which represents the first time that Alzheimer's-like plaques have been visualized in vivo in living animals -- sets the stage for the refinement of this dye-like compound so it may be used to diagnose and monitor the treatment of patients with Alzheimer's disease. At the present time, diagnostic confirmation and visualization of the plaque burden in the brains of Alzheimer's patients can occur only after death, during postmortem autopsy.

"This is definitely proof of concept," says Dr. Lee, Professor of Pathology & Laboratory Medicine at Penn and lead author of the study that appears in the June 20 issue of Proceedings of the National Academy of Science. "We have demonstrated for the first time that a flurogenic probe can cross the blood-brain barrier and bind to amyloid plaques in the brains of transgenic mice that develop such plaques. This is an essential first step for the development of an antemortem diagnostic for Alzheimer's disease."

"This research is an enormously important step toward developing an imaging method that could pinpoint the telltale signs of plaque development associated with Alzheimer's disease in a living brain," echoes Marcelle Morrison-Bogorad, PhD, Associate Director of Neuroscience and Neuropsychology of Aging at the National Institute on Aging in Bethesda, Maryland, which provided the major funding for the study. "This tool could help clinicians peer into a person's brain and monitor amyloid levels in response to treatment. We definitely need something like this to advance the diagnosis and treatment of dementia."

For now, Dr. Lee and her research team will continue to fine-tune BSB (by, perhaps, further increasing its solubility and/or decreasing its molecular weight) and also work to develop an efficient radioactive marker to enhance visualization during PET or SPECT imaging. "The exciting promise of our agent is that, when clinically applied, it will demonstrate efficacy of therapy in treatments designed to inhibit the growth of amyloids," explains Dr. Lee.

As described by the published study, the step-by-step development of the BSB molecular probe was meticulously charted. The design and synthesis of BSB was the ingenious work of Dr. Hank Kung, a co-author of the study, who is highly regarded for creating other imaging molecules that have become essential diagnostic brain-imaging probes now in use throughout the United States and abroad. After determining that BSB could enter cells (by using human cells in culture) and that the agent could be picked-up by normal brain cells (by injecting the compound into the brains of non-diseased mice), the scientists focused their attention on transgenic mice modeled for Alzheimer's disease. At this point, they injected BSB directly into the hippocampus of about a half-dozen transgenic mice to see if they could induce labelling of the plaques close to the injection site. Post-mortem analysis of those brain sections showed that BSB produced clear and distinctive visual identification of the amyloid plaques.

"Our next step was the Holy Grail," remembers Dr. Lee, whose team still had to prove that their new compound was strong enough, small enough, and soluble enough to efficiently pass through the Berlin Wall-like defense of the blood-brain barrier. To that end, BSB was injected into the veins of transgenic mice. Again, post-mortem studies of the animals' brains showed clearly-discernible plaques. In addition, the investigators learned that BSB bound to amyloid plaques remained stable for at least 18 hours. "We demonstrated unequivocably that the compound can go through the blood-brain barrier and bind to amyloid," says Dr. Lee.

###

The work was supported by grants from the National Institute on Aging and by the estate of Mona Schneidman. Other investigators on the study included Daniel M. Skovronsky ,PhD; Bin Zhang, PhD; Mei-Ping Kung, PhD; Hank F. Kung, PhD; and John Q. Trojanowski, MD, PhD.


Story Source:

The above story is based on materials provided by University Of Pennsylvania Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Pennsylvania Medical Center. "New Compound May Permit Definitive Diagnosis And Treatment Monitoring Of Alzheimer's In Living Patients." ScienceDaily. ScienceDaily, 27 June 2000. <www.sciencedaily.com/releases/2000/06/000625234118.htm>.
University Of Pennsylvania Medical Center. (2000, June 27). New Compound May Permit Definitive Diagnosis And Treatment Monitoring Of Alzheimer's In Living Patients. ScienceDaily. Retrieved November 26, 2014 from www.sciencedaily.com/releases/2000/06/000625234118.htm
University Of Pennsylvania Medical Center. "New Compound May Permit Definitive Diagnosis And Treatment Monitoring Of Alzheimer's In Living Patients." ScienceDaily. www.sciencedaily.com/releases/2000/06/000625234118.htm (accessed November 26, 2014).

Share This


More From ScienceDaily



More Mind & Brain News

Wednesday, November 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Are Female Bosses More Likely To Be Depressed?

Are Female Bosses More Likely To Be Depressed?

Newsy (Nov. 24, 2014) A new study links greater authority with increased depressive symptoms among women in the workplace. Video provided by Newsy
Powered by NewsLook.com
Winter Can Cause Depression — Here's How To Combat It

Winter Can Cause Depression — Here's How To Combat It

Newsy (Nov. 23, 2014) Millions of American suffer from seasonal depression every year. It can lead to adverse health effects, but there are ways to ease symptoms. Video provided by Newsy
Powered by NewsLook.com
Could Your Genes Be The Reason You're Single?

Could Your Genes Be The Reason You're Single?

Newsy (Nov. 21, 2014) Researchers in Beijing discovered a gene called 5-HTA1, and carriers are reportedly 20 percent more likely to be single. Video provided by Newsy
Powered by NewsLook.com
Milestone Birthdays Can Bring Existential Crisis, Study Says

Milestone Birthdays Can Bring Existential Crisis, Study Says

Newsy (Nov. 21, 2014) Researchers find that as people approach new decades in their lives they make bigger life decisions. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins